Evidence map›Paper›PMID 23363994›Full record

ArticleNutrients2012

Dose and latency effects of leucine supplementation in modulating glucose homeostasis: opposite effects in healthy and glucocorticoid-induced insulin-resistance states.

Nelo Eidy Zanchi, Lucas Guimarães-Ferreira, Mário Alves de Siqueira-Filho, Vitor Felitti, Humberto Nicastro, Carlos Bueno, Fábio Santos Lira, Marshall Alan Naimo, Patrícia Campos-Ferraz, Maria Tereza Nunes and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Nelo Eidy ZanchiLaboratory of Applied Nutrition and Metabolism, School of Physical Education and Sports, University of Sao Paulo, Sao Paulo, Brazil. neloz@ig.com.br
Lucas Guimarães-Ferreira
Mário Alves de Siqueira-Filho
Vitor Felitti
Humberto Nicastro
Carlos Bueno
Fábio Santos Lira
Marshall Alan Naimo
Patrícia Campos-Ferraz
Maria Tereza Nunes
Marília Seelaender
Carla Roberta de Oliveira Carvalho
François Blachier
Antonio Herbert Lancha
Universidade de São Paulo · BRAgroParisTech · FRUniversity of Tampa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dexamethasone (DEXA) is a potent immunosupressant and anti-inflammatory agent whose main side effects are muscle atrophy and insulin resistance in skeletal muscles. In this context, leucine supplementation may represent a way to limit the DEXA side effects. In this study, we have investigated the effects of a low and a high dose of leucine supplementation (via a bolus) on glucose homeostasis, muscle mass and muscle strength in energy-restricted and DEXA-treated rats. Since the leucine response may also be linked to the administration of this amino acid, we performed a second set of experiments with leucine given in bolus (via gavage) versus leucine given via drinking water. Leucine supplementation was found to produce positive effects (e.g., reduced insulin levels) only when administrated in low dosage, both via the bolus or via drinking water. However, under DEXA treatment, leucine administration was found to significantly influence this response, since leucine supplementation via drinking water clearly induced a diabetic state, whereas the same effect was not observed when supplied via the gavage.

Indexed as

Insulin ResistanceAnimalsBlood GlucoseDexamethasoneDietary SupplementsDose-Response Relationship, DrugDrug Administration RoutesGlucocorticoidsHomeostasisInsulinLeucineMaleMuscle, SkeletalMuscle StrengthMuscular AtrophyRatsBlood GlucoseDexamethasoneGlucocorticoidsInsulinLeucine

Identifiers

PMID23363994
PMCPMC3546611
OpenAlexW1974668746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.